2020 ASCO Virtual Scientific Meeting

May 29-31, 2020; Online at meetings.asco.org/am
Review slidesets and expert analyses of key data from the 2020 Clinical Oncology Virtual Scientific Meeting!

Share

Program Content

Activities

Key Studies at ASCO 2020
An Expert’s Guide to ASCO 2020: A Preview of the Top Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 27, 2020

13 Capsule Summary Slidesets

Activities

DESTINY-Lung01
Phase II DESTINY-Lung01: Interim Analysis of Trastuzumab Deruxtecan in Patients With HER2-Mutated NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2020

Expires: May 29, 2021

KEYNOTE-604
KEYNOTE-604 Final Analysis: Addition of Pembrolizumab to Etoposide and Platinum in Extensive-Stage SCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

CASPIAN
CASPIAN: Phase III Study of First-line Durvalumab + Tremelimumab + EP vs Durvalumab + EP vs EP Alone in Extensive-Stage SCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

CheckMate 227: 3-Year Update
First-line Nivolumab Plus Ipilimumab vs Chemotherapy in Advanced NSCLC: 3-Year Update of CheckMate 227 Part 1
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

ADAURA: Adj Osimertinib
Phase III ADAURA: Adjuvant Osimertinib vs Placebo After Complete Resection in Patients With Stage IB-IIIA EGFR-Mutated NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

CheckMate 9LA
CheckMate 9LA: Nivolumab and Ipilimumab Plus 2 Cycles of Platinum-Doublet Chemotherapy vs 4 Cycles Chemotherapy as First-line Treatment for Advanced Non-small Cell Lung Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2020

Expires: June 01, 2021

RESILIENT: Liposomal Irinotecan
RESILIENT Part 1: Phase II Study of Liposomal Irinotecan After Platinum Chemotherapy in Small-Cell Lung Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

Lurbinectedin Plus Irinotecan
Phase Ib/II Trial of Lurbinectedin Plus Irinotecan in Patients With Advanced Solid Tumors
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

GEOMETRY: Capmatinib in METamp+ NSCLC
Phase II GEOMETRY mono-1: Capmatinib in Patients With NSCLC and High MET Amplification
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

SINDAS Interim Analysis
Phase III SINDAS: Interim Analysis of First-line EGFR TKI With vs Without SBRT in Patients With EGFR-Mutated Oligometastatic NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

CITYSCAPE: Tiragolumab
Phase II CITYSCAPE: Addition of Tiragolumab, an Anti-TIGIT Antibody, to First-line Atezolizumab in PD-L1–Selected Metastatic NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

ARROW: Pralsetinib in <i>RET</i>+ NSCLC
Phase I/II ARROW: Registrational Dataset of RET Inhibitor Pralsetinib (BLU-667) in Patients With Advanced RET Fusion–Positive NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2020

Expires: June 07, 2021

ADJUVANT-CTONG 1104
ADJUVANT-CTONG 1104: Final OS Analysis of Phase III Study of Adjuvant Gefitinib vs Chemotherapy in Chinese Patients With Resected EGFR-Mutated NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2020

Expires: June 08, 2021

Activities

ASCO 2020: Key Lung Cancer Studies
Key Studies in Lung Cancer: Independent Conference Coverage of the ASCO 2020 Scientific Meeting
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2020

Expires: September 24, 2021

EP: Lung Cancer
ExpressPoints: Key Studies in Lung Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2020

Expires: September 24, 2021

14 Capsule Summary Slidesets

Activities

MONALEESA Pooled Analysis
Biomarkers of Response or Resistance to Ribociclib + Endocrine Therapy for Advanced Breast Cancer: Pooled Analysis of MONALEESA Phase III Trials
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2020

Expires: May 30, 2021

Niraparib Dosing
Optimal Dosing of the Poly(ADP-Ribose) Polymerase Inhibitor Niraparib
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

KEYNOTE-355 Safety + Efficacy
KEYNOTE-355: Pembrolizumab + Chemotherapy for Previously Untreated Advanced Triple-Negative Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

CompLEEment-1
CompLEEment-1: Updated Results From the Phase IIIb Study of Ribociclib Plus Letrozole in HR+, HER2- Advanced Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

SOLO2 Final OS Analysis
SOLO2: Final OS Analysis of Maintenance Olaparib in Platinum-Sensitive, Relapsed Ovarian Cancer with BRCA Mutation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

HER2CLIMB CNS Analysis
HER2CLIMB: Tucatinib Plus Trastuzumab and Capecitabine in Previously Treated HER2-Positive MBC With Brain Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2020

Expires: June 01, 2021

DESKTOP III: Surgery in PSROC
DESKTOP III: Improved Survival With Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

BYLieve: Alpelisib After CDK4/6i
Phase II BYLieve: Alpelisib Plus Fulvestrant in PIK3CA-Mutated HR+/HER2- Advanced Breast Cancer After CDK4/6 Inhibitor Plus AI
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

MONALEESA-3/-7 Pooled
MONALEESA-3/-7 Pooled OS Analysis: Ribociclib Plus ET in Patients With HR+/HER2- Advanced Breast Cancer and Visceral Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2020

Expires: June 02, 2021

SWOG 1416: Plt Plus PARPi
Phase II SWOG 1416: Cisplatin Plus Veliparib or Placebo in Metastatic TNBC and BRCA Mutation–Associated Breast Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

Lenvatinib/Pembrolizumab
KEYNOTE-146: Lenvatinib Plus Pembrolizumab as Early-Line Treatment of Advanced Endometrial Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

AVANOVA2 Update
AVANOVA2 Extended Follow-up: Niraparib Plus Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2020

Expires: June 07, 2021

KEYNOTE-100
KEYNOTE-100: Final Results From Phase II Study on Pembrolizumab Monotherapy for Advanced Recurrent Ovarian Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2020

Expires: June 07, 2021

E2108: Local Tx in de novo MBC
ECOG-ACRIN 2108: Phase III Trial Evaluating the Role of Early Local Therapy for Patients With Metastatic Breast Cancer and an Intact Primary Tumor
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2020

Expires: June 08, 2021

Activities

<i>EP</i>: Breast and GYN
ExpressPoints: Key Studies in Breast and Gynecologic Cancers
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2020

Expires: September 08, 2021

ASCO 2020 Breast/Gyn
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2020

Expires: September 08, 2021

6 Capsule Summary Slidesets

Activities

DESTINY-Gastric01
DESTINY-Gastric01: Trastuzumab Deruxtecan in Previously Treated, HER2+ Advanced Gastric or GEJ Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

DESTINY-CRC01
Phase II DESTINY-CRC01: Trastuzumab Deruxtecan in Patients With HER2-Expressing Metastatic Colorectal Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2020

Expires: May 31, 2021

RTOG 1010
Phase III RTOG 1010: Addition of Trastuzumab to Trimodality Treatment in Resectable HER2-Positive Esophageal Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2020

Expires: June 01, 2021

SWOG S1505
SWOG S1505: Phase II Study of Perioperative CT With mFOLFIRINOX vs Gemcitabine/nab-Paclitaxel in Resectable Pancreatic Ductal Adenocarcinoma
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

KEYNOTE-177
KEYNOTE-177: Phase III Trial of First-line Pembrolizumab vs Chemotherapy in MSI-H/dMMR Metastatic CRC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2020

Expires: June 03, 2021

PRODIGE 23
PRODIGE 23: Phase III Trial of Neoadjuvant mFOLFIRINOX Plus CRT vs Preoperative CRT in Locally Advanced Rectal Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2020

Expires: June 04, 2021

Activities

Downloadable Slideset
Key Studies in Gastrointestinal Cancers from the 2020 ASCO Virtual Scientific Meeting
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 07, 2020

Expires: August 06, 2021

Expert Analysis
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 07, 2020

Expires: August 06, 2021

Faculty

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Stephen Liu, MD

Assistant Professor of Medicine
Department of Medical Oncology
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

cover img faculity

Daniel P. Petrylak, MD

Professor of Medicine
Smilow Cancer Center
Yale University Medical Center
New Haven, Connecticut

cover img faculity

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Daiichi Sankyo, Inc.

Exelixis

GlaxoSmithKline

Ipsen Biopharmaceuticals Inc

Jazz Pharmaceuticals

Jazz Pharmaceuticals Inc

Karyopharm Therapeutics

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation

Pfizer and EMD Serono